These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20150804)

  • 21. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative assessment of efficacy of dysport (botulinum toxin type A) in the treatment of idiopathic blepharospasm and hemifacial spasm.
    Tsai CP; Chiu MC; Yen DJ; Guo YC; Yuan CL; Lee TC
    Acta Neurol Taiwan; 2005 Jun; 14(2):61-8. PubMed ID: 16008164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dysphagia as a side effect of botulinum toxin injection.
    Kwek AB; Tan EK; Luman W
    Med J Malaysia; 2004 Oct; 59(4):544-6. PubMed ID: 15779592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Supramaximal doses of botulinum toxin for refractory blepharospasm.
    Levy RL; Berman D; Parikh M; Miller NR
    Ophthalmology; 2006 Sep; 113(9):1665-8. PubMed ID: 16828511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group].
    Wissel J; Müller J; Heinen F; Mall V; Sojer M; Ebersbach G; Poewe W
    Wien Klin Wochenschr; 1999 Oct; 111(20):837-42. PubMed ID: 10586488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical research of electroacupuncture combined with acupoint-injection of botulinum toxin A in treating the muscle spasticity by spinal cord injury].
    Xing ST; Wang D; Wen XH; Wu ZQ; Sun Q; Zhang DW; Cheng Y; Yan D; Yu F
    Zhongguo Gu Shang; 2010 May; 23(5):350-3. PubMed ID: 20575288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
    Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
    Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case of iatrogenic botulism after botulinotherapy in clinical practice.
    Ibatullin RA; Magjanov RV
    Ter Arkh; 2018 Nov; 90(11):102-104. PubMed ID: 30701823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Iatrogenic botulism after the therapeutic use of botulinum toxin-A: a case report and review of the literature.
    Ghasemi M; Norouzi R; Salari M; Asadi B
    Clin Neuropharmacol; 2012; 35(5):254-7. PubMed ID: 22986799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical evidence of extraocular muscle fiber-type specificity of botulinum toxin.
    Stahl JS; Averbuch-Heller L; Remler BF; Leigh RJ
    Neurology; 1998 Oct; 51(4):1093-9. PubMed ID: 9781535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iatrogenic botulism in a child with spastic quadriparesis.
    Partikian A; Mitchell WG
    J Child Neurol; 2007 Oct; 22(10):1235-7. PubMed ID: 17940253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature.
    Leonardi L; Haggiag S; Petrucci A; Lispi L
    J Clin Neurosci; 2019 Feb; 60():138-141. PubMed ID: 30348587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contralateral weakness and fatigue after high-dose botulinum toxin injection for management of poststroke spasticity.
    Varghese-Kroll E; Elovic EP
    Am J Phys Med Rehabil; 2009 Jun; 88(6):495-9. PubMed ID: 19454855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Practice of botulism].
    Ikeguchi K
    Brain Nerve; 2011 Jul; 63(7):763-73. PubMed ID: 21747147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Botulism in 4 adults following cosmetic injections with an unlicensed, highly concentrated botulinum preparation.
    Chertow DS; Tan ET; Maslanka SE; Schulte J; Bresnitz EA; Weisman RS; Bernstein J; Marcus SM; Kumar S; Malecki J; Sobel J; Braden CR
    JAMA; 2006 Nov; 296(20):2476-9. PubMed ID: 17119144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A Descriptive Series of Patient Features and Outcome.
    Rashid EAMA; El-Mahdy NM; Kharoub HS; Gouda AS; ElNabarawy NA; Mégarbane B
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):622-627. PubMed ID: 29786953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years.
    Mauriello JA; Dhillon S; Leone T; Pakeman B; Mostafavi R; Yepez MC
    Br J Ophthalmol; 1996 Dec; 80(12):1073-6. PubMed ID: 9059273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.